// App-Quantinova.ai

: PREDICTIVE VALUE AND POTENTIALS FOR CO-TARGETED THERAPY OF STAT1 SIGNALING IN GEMCITABINE/CISPLATIN RESISTANT BLADDER CANCER

Researchers

Presenter

  • Tetsutaro Hayashi

Principal Investigators

  • Kenichiro Ikeda

  • Roland Seiler

  • Robert H Bell

  • Susan Ettinger

  • Kendric Wang

  • Htoo Zarni Oo

  • Hamidreza Abdi

  • Wolfgang Jaeger

  • Tilman Todenhoefer

  • Colin Collins

  • Akio Matsubara

  • Peter C Black

Medical Centers

  • N/A

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

Biomarkers

  • Signal Transducer And Activator Of Transcription 1

Drug/Treatment

  • Gemcitabine

  • Cisplatin

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved